Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $691.4300 (0.85%) ($691.4300 - $691.4300) on Wed. May. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.66% (three month average) | RSI | 67 | Latest Price | $691.4300(0.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN advances 4.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(39%) IWD(37%) SPLV(36%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -0.83% in a week (0% probabilities). VIXM(-14%) TBT(-11%) UUP(-7%) VXX(-2%) USO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.83% (StdDev 1.66%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $675.54(2.35%) | 10 Day Moving Average | $664.77(4.01%) | 20 Day Moving Average | $652.21(6.01%) | To recent high | -6.4% | To recent low | 15.2% | Market Cap | $73.311b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |